{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:05:57Z","timestamp":1779894357195,"version":"3.53.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03608-z","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T21:03:09Z","timestamp":1700514189000},"page":"223-235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical characteristics, densitometric parameters and outcomes of patients with atypical femoral fractures related to bisphosphonate treatment for osteoporosis"],"prefix":"10.1007","volume":"84","author":[{"given":"Chun Ho","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy Ka Chun","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly Hang","family":"Tsoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey Sheung Yi","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy Su","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie Hong Nin","family":"Loong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol Ho Yi","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janus Siu Him","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham Ka Hon","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching Lung","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn Choon Beng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Cho","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9813-1126","authenticated-orcid":false,"given":"David Tak Wai","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,20]]},"reference":[{"key":"3608_CR1","first-page":"1","volume":"19","author":"TP Ip","year":"2013","unstructured":"T.P. Ip, S.K. Cheung, T.C. Cheung et al. The Osteoporosis Society of Hong Kong (OSHK): 2013 OSHK guideline for clinical management of postmenopausal osteoporosis in Hong Kong. Hong Kong Med. J. 19, 1\u201340 (2013)","journal-title":"Hong Kong Med. J."},{"key":"3608_CR2","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3949\/ccjm.85a.17119","volume":"85","author":"S Silverman","year":"2018","unstructured":"S. Silverman, E. Kupperman, S. Bukata, Bisphosphonate-related atypical femoral fracture: managing a rare but serious complication. Cleve Clin. J. Med. 85, 885\u2013893 (2018). https:\/\/doi.org\/10.3949\/ccjm.85a.17119","journal-title":"Cleve Clin. J. Med."},{"key":"3608_CR3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1056\/NEJMoa1916525","volume":"383","author":"DM Black","year":"2020","unstructured":"D.M. Black, E.J. Geiger, R. Eastell et al. Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates. N. Engl. J. Med. 383, 743\u2013753 (2020). https:\/\/doi.org\/10.1056\/NEJMoa1916525","journal-title":"N. Engl. J. Med."},{"key":"3608_CR4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11914-018-0464-6","volume":"16","author":"J Starr","year":"2018","unstructured":"J. Starr, Y.K.D. Tay, E. Shane, Current understanding of epidemiology, pathophysiology, and management of atypical femur fractures. Curr. Osteoporos. Rep. 16, 519\u2013529 (2018). https:\/\/doi.org\/10.1007\/s11914-018-0464-6","journal-title":"Curr. Osteoporos. Rep."},{"key":"3608_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/jbmr.4461","volume":"37","author":"MJ B\u00e9gin","year":"2022","unstructured":"M.J. B\u00e9gin, M.C. Audet, T. Chevalley et al. Fracture risk following an atypical femoral fracture. J. Bone Miner. Res. 37, 87\u201394 (2022). https:\/\/doi.org\/10.1002\/jbmr.4461","journal-title":"J. Bone Miner. Res."},{"key":"3608_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"E. Shane, D. Burr, B. Abrahamsen et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J. Bone Miner. Res. 29, 1\u201323 (2014). https:\/\/doi.org\/10.1002\/jbmr.1998","journal-title":"J. Bone Miner. Res."},{"key":"3608_CR7","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1210\/clinem\/dgac684","volume":"108","author":"CH Wong","year":"2023","unstructured":"C.H. Wong, E.K.H. Leung, L.C.K. Tang et al. Effect of inactivated and mRNA COVID-19 vaccination on thyroid function among patients treated for hyperthyroidism. J. Clin. Endocrinol. Metab. 108, e76\u2013e88 (2023). https:\/\/doi.org\/10.1210\/clinem\/dgac684","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3608_CR8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s40618-020-01337-y","volume":"44","author":"DTW Lui","year":"2021","unstructured":"D.T.W. Lui, C.H. Lee, V.W.K. Chau et al. Potential role of fibroblast growth factor 21 in the deterioration of bone quality in impaired glucose tolerance. J. Endocrinol. Investig. 44, 523\u2013530 (2021). https:\/\/doi.org\/10.1007\/s40618-020-01337-y","journal-title":"J. Endocrinol. Investig."},{"key":"3608_CR9","unstructured":"UO Sheffield UK FRAX_ WHO fracture risk assessment tool. (2021) https:\/\/www.sheffield.ac.uk\/FRAX\/tool.aspx?country=20. Accessed 7 Jul 2023"},{"key":"3608_CR10","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s00268-020-05842-2","volume":"45","author":"DTW Lui","year":"2021","unstructured":"D.T.W. Lui, M.M.H. Fung, C.H. Lee et al. The potential role of preoperative trabecular bone score in predicting changes in bone mineral density after parathyroidectomy. World J. Surg. 45, 522\u2013530 (2021). https:\/\/doi.org\/10.1007\/s00268-020-05842-2","journal-title":"World J. Surg."},{"key":"3608_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11914-007-0002-4","volume":"5","author":"TJ Beck","year":"2007","unstructured":"T.J. Beck, Extending DXA beyond bone mineral density: understanding hip structure analysis. Curr. Osteoporos. Rep. 5, 49\u201355 (2007). https:\/\/doi.org\/10.1007\/s11914-007-0002-4","journal-title":"Curr. Osteoporos. Rep."},{"key":"3608_CR12","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s00774-010-0242-8","volume":"29","author":"J Takada","year":"2011","unstructured":"J. Takada, G. Katahira, K. Iba, T. Yoshizaki, T. Yamashita, Hip structure analysis of bisphosphonate-treated Japanese postmenopausal women with osteoporosis. J. Bone Miner. Metab. 29, 458\u2013465 (2011). https:\/\/doi.org\/10.1007\/s00774-010-0242-8","journal-title":"J. Bone Miner. Metab."},{"key":"3608_CR13","doi-asserted-by":"publisher","first-page":"e4848","DOI":"10.1210\/clinem\/dgaa647","volume":"105","author":"TV Joseph","year":"2020","unstructured":"T.V. Joseph, S. Caksa, M. Misra, D.M. Mitchell, Hip structural analysis reveals impaired hip geometry in girls with type 1 diabetes. J. Clin. Endocrinol. Metab. 105, e4848\u2013e4856 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa647","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3608_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bone.2016.01.002","volume":"85","author":"JC Lo","year":"2016","unstructured":"J.C. Lo, R.L. Hui, C.D. Grimsrud et al. The association of race\/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy. Bone 85, 142\u2013147 (2016). https:\/\/doi.org\/10.1016\/j.bone.2016.01.002","journal-title":"Bone"},{"key":"3608_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3109\/17453674.2015.1004149","volume":"86","author":"J Schilcher","year":"2015","unstructured":"J. Schilcher, V. Koeppen, P. Aspenberg, K. Micha\u00eblsson, Risk of atypical femoral fracture during and after bisphosphonate use. Acta Orthop 86, 100\u2013107 (2015). https:\/\/doi.org\/10.3109\/17453674.2015.1004149","journal-title":"Acta Orthop"},{"key":"3608_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMcp1513724","volume":"374","author":"DM Black","year":"2016","unstructured":"D.M. Black, C.J. Rosen, Clinical practice. Postmenopausal osteoporosis. N. Engl. J. Med. 374, 254\u2013262 (2016). https:\/\/doi.org\/10.1056\/NEJMcp1513724","journal-title":"N. Engl. J. Med."},{"key":"3608_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/jbmr.2708","volume":"31","author":"RA Adler","year":"2016","unstructured":"R.A. Adler, G. El-Hajj Fuleihan, D.C. Bauer et al. Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research. J. Bone Miner. Res. 31, 16\u201335 (2016). https:\/\/doi.org\/10.1002\/jbmr.2708","journal-title":"J. Bone Miner. Res."},{"key":"3608_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bone.2010.05.019","volume":"47","author":"A Giusti","year":"2010","unstructured":"A. Giusti, N.A. Hamdy, S.E. Papapoulos, Atypical fractures of the femur and bisphosphonate therapy: a systematic review of case\/case series studies. Bone 47, 169\u2013180 (2010). https:\/\/doi.org\/10.1016\/j.bone.2010.05.019","journal-title":"Bone"},{"key":"3608_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00774-014-0591-9","volume":"33","author":"Y Saita","year":"2015","unstructured":"Y. Saita, M. Ishijima, A. Mogami et al. The incidence of and risk factors for developing atypical femoral fractures in Japan. J. Bone Miner. Metab. 33, 311\u2013318 (2015). https:\/\/doi.org\/10.1007\/s00774-014-0591-9","journal-title":"J. Bone Miner. Metab."},{"key":"3608_CR20","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1007\/s00198-017-4169-y","volume":"28","author":"JH Koh","year":"2017","unstructured":"J.H. Koh, J.P. Myong, J. Yoo et al. Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years\u2019 experience in a single center. Osteoporos. Int. 28, 3251\u20133259 (2017). https:\/\/doi.org\/10.1007\/s00198-017-4169-y","journal-title":"Osteoporos. Int."},{"key":"3608_CR21","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1210\/jc.2012-1896","volume":"98","author":"N Napoli","year":"2013","unstructured":"N. Napoli, A.V. Schwartz, L. Palermo et al. Risk factors for subtrochanteric and diaphyseal fractures: the study of osteoporotic fractures. J. Clin. Endocrinol. Metab. 98, 659\u2013667 (2013). https:\/\/doi.org\/10.1210\/jc.2012-1896","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3608_CR22","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1002\/jbmr.3221","volume":"32","author":"ES LeBlanc","year":"2017","unstructured":"E.S. LeBlanc, A.G. Rosales, D.M. Black et al. Evaluating atypical features of femur fractures: how change in radiological criteria influenced incidence and demography of atypical femur fractures in a community setting. J. Bone Miner. Res. 32, 2304\u20132314 (2017). https:\/\/doi.org\/10.1002\/jbmr.3221","journal-title":"J. Bone Miner. Res."},{"key":"3608_CR23","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.bone.2013.07.010","volume":"56","author":"P Franceschetti","year":"2013","unstructured":"P. Franceschetti, M. Bondanelli, G. Caruso et al. Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy. Bone 56, 426\u2013431 (2013). https:\/\/doi.org\/10.1016\/j.bone.2013.07.010","journal-title":"Bone"},{"key":"3608_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bone.2012.02.632","volume":"51","author":"JC Lo","year":"2012","unstructured":"J.C. Lo, S.Y. Huang, G.A. Lee et al. Clinical correlates of atypical femoral fracture. Bone 51, 181\u2013184 (2012). https:\/\/doi.org\/10.1016\/j.bone.2012.02.632","journal-title":"Bone"},{"key":"3608_CR25","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/jbmr.2107","volume":"29","author":"MB Zanchetta","year":"2014","unstructured":"M.B. Zanchetta, M. Diehl, M. Buttazzoni et al. Assessment of bone microarchitecture in postmenopausal women on long-term bisphosphonate therapy with atypical fractures of the femur. J. Bone Miner. Res. 29, 999\u20131004 (2014). https:\/\/doi.org\/10.1002\/jbmr.2107","journal-title":"J. Bone Miner. Res."},{"key":"3608_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jocd.2018.03.005","volume":"22","author":"SKC Buitendijk","year":"2019","unstructured":"S.K.C. Buitendijk, D.M. van de Laarschot, A.A.A. Smits et al. Trabecular bone score and hip structural analysis in patients with atypical femur fractures. J. Clin. Densitom. 22, 257\u2013265 (2019). https:\/\/doi.org\/10.1016\/j.jocd.2018.03.005","journal-title":"J. Clin. Densitom."},{"key":"3608_CR27","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/jbmr.2748","volume":"31","author":"Z Mahjoub","year":"2016","unstructured":"Z. Mahjoub, S. Jean, J.T. Leclerc et al. Incidence and characteristics of atypical femoral fractures: clinical and geometrical data. J. Bone Miner. Res. 31, 767\u2013776 (2016). https:\/\/doi.org\/10.1002\/jbmr.2748","journal-title":"J. Bone Miner. Res."},{"key":"3608_CR28","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.2106\/jbjs.N.00075","volume":"96","author":"JE Hagen","year":"2014","unstructured":"J.E. Hagen, A.N. Miller, S.M. Ott et al. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry. J. Bone Joint Surg. Am. 96, 1905\u20131909 (2014). https:\/\/doi.org\/10.2106\/jbjs.N.00075","journal-title":"J. Bone Joint Surg. Am."},{"key":"3608_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bone.2014.02.006","volume":"63","author":"DP Taormina","year":"2014","unstructured":"D.P. Taormina, A.I. Marcano, R. Karia, K.A. Egol, N.C. Tejwani, Symptomatic atypical femoral fractures are related to underlying hip geometry. Bone 63, 1\u20136 (2014). https:\/\/doi.org\/10.1016\/j.bone.2014.02.006","journal-title":"Bone"},{"key":"3608_CR30","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/jbmr.2767","volume":"31","author":"M Kharazmi","year":"2016","unstructured":"M. Kharazmi, P. Hallberg, J. Schilcher, P. Aspenberg, K. Micha\u00eblsson, Mortality after atypical femoral fractures: a cohort study. J. Bone Miner. Res. 31, 491\u2013497 (2016). https:\/\/doi.org\/10.1002\/jbmr.2767","journal-title":"J. Bone Miner. Res."},{"key":"3608_CR31","doi-asserted-by":"publisher","first-page":"e10515","DOI":"10.1002\/jbm4.10515","volume":"5","author":"L Gani","year":"2021","unstructured":"L. Gani, N. Anthony, L. Dacay, P. Tan, L.R. Chong, T.F. King, Incidence of atypical femoral fracture and its mortality in a single center in Singapore. JBMR Plus 5, e10515 (2021). https:\/\/doi.org\/10.1002\/jbm4.10515","journal-title":"JBMR Plus"},{"key":"3608_CR32","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/jbmr.253","volume":"25","author":"E Shane","year":"2010","unstructured":"E. Shane, D. Burr, P.R. Ebeling et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J. Bone Miner. Res. 25, 2267\u20132294 (2010). https:\/\/doi.org\/10.1002\/jbmr.253","journal-title":"J. Bone Miner. Res."},{"key":"3608_CR33","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1210\/clinem\/dgz295","volume":"105","author":"DM van de Laarschot","year":"2020","unstructured":"D.M. van de Laarschot, M.J. McKenna, B. Abrahamsen et al. Medical management of patients after atypical femur fractures: a systematic review and recommendations from the European Calcified Tissue Society. J Clin. Endocrinol. Metab. 105, 1682\u20131699 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgz295","journal-title":"J Clin. Endocrinol. Metab."},{"key":"3608_CR34","doi-asserted-by":"publisher","unstructured":"S.E. Byun, K.J. Lee, W.C. Shin, N.H. Moon, C.H. Kim, The effect of teriparatide on fracture healing after atypical femoral fracture: a systematic review and meta-analysis. Osteoporos. Int. (2023). https:\/\/doi.org\/10.1007\/s00198-023-06768-w","DOI":"10.1007\/s00198-023-06768-w"},{"key":"3608_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00590-014-1443-y","volume":"25","author":"EG Ballas","year":"2015","unstructured":"E.G. Ballas, A.F. Mavrogenis, E. Karamanis et al. Low-energy femoral shaft fractures after long-term alendronate therapy: report of seven cases. Eur. J. Orthop. Surg. Traumatol. 25, 181\u2013187 (2015). https:\/\/doi.org\/10.1007\/s00590-014-1443-y","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"key":"3608_CR36","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00198-015-3354-0","volume":"27","author":"SK Ramchand","year":"2016","unstructured":"S.K. Ramchand, C.Y. Chiang, R.M. Zebaze, E. Seeman, Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report. Osteoporos. Int. 27, 821\u2013825 (2016). https:\/\/doi.org\/10.1007\/s00198-015-3354-0","journal-title":"Osteoporos. Int."},{"key":"3608_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/17453674.2013.854668","volume":"85","author":"E Drampalos","year":"2014","unstructured":"E. Drampalos, G. Skarpas, N. Barbounakis, I. Michos, Atypical femoral fractures bilaterally in a patient receiving denosumab. Acta Orthop. 85, 3\u20135 (2014). https:\/\/doi.org\/10.3109\/17453674.2013.854668","journal-title":"Acta Orthop."},{"key":"3608_CR38","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/s0140-6736(21)02646-5","volume":"399","author":"IR Reid","year":"2022","unstructured":"I.R. Reid, E.O. Billington, Drug therapy for osteoporosis in older adults. Lancet 399, 1080\u20131092 (2022). https:\/\/doi.org\/10.1016\/s0140-6736(21)02646-5","journal-title":"Lancet"},{"key":"3608_CR39","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","volume":"377","author":"KG Saag","year":"2017","unstructured":"K.G. Saag, J. Petersen, M.L. Brandi et al. Romosozumab or alendronate for fracture prevention in women with osteoporosis. N. Engl. J. Med. 377, 1417\u20131427 (2017). https:\/\/doi.org\/10.1056\/NEJMoa1708322","journal-title":"N. Engl. J. Med."},{"key":"3608_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00198-014-2885-0","volume":"26","author":"SH Tan","year":"2015","unstructured":"S.H. Tan, S. Saseendar, B.H. Tan, A. Pawaskar, V.P. Kumar, Ulnar fractures with bisphosphonate therapy: a systematic review of published case reports. Osteoporos. Int. 26, 421\u2013429 (2015). https:\/\/doi.org\/10.1007\/s00198-014-2885-0","journal-title":"Osteoporos. Int."},{"key":"3608_CR41","doi-asserted-by":"publisher","first-page":"115726","DOI":"10.1016\/j.bone.2020.115726","volume":"143","author":"N Binkley","year":"2021","unstructured":"N. Binkley, H. Goel, E. Shives, D. Krueger, K. Hare, A probable atypical ulnar fracture in a man receiving denosumab. Bone 143, 115726 (2021). https:\/\/doi.org\/10.1016\/j.bone.2020.115726","journal-title":"Bone"},{"key":"3608_CR42","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jconrel.2022.07.012","volume":"349","author":"L Subedi","year":"2022","unstructured":"L. Subedi, P. Pandey, S.H. Kang et al. Enhanced oral absorption of teriparatide with therapeutic potential for management of osteoporosis. J. Control Release 349, 502\u2013519 (2022). https:\/\/doi.org\/10.1016\/j.jconrel.2022.07.012","journal-title":"J. Control Release"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03608-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03608-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03608-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T02:06:16Z","timestamp":1712109976000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03608-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,20]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["3608"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03608-z","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,20]]},"assertion":[{"value":"19 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study followed the principles in the Declaration of Helsinki and was approved by the Institutional Review Board of the University of Hong Kong\/Hospital Authority Hong Kong West Cluster (UW 22-043).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}